ENDRA Life Sciences Inc.
NDRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $7 | $6,337 | $13,749 | $49,543 |
| - Cash | $3 | $3 | $5 | $9 |
| + Debt | $1 | $0 | $1 | $1 |
| Enterprise Value | $4 | $6,334 | $13,744 | $49,534 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$11 | -$10 | -$13 | -$11 |
| % Margin | – | – | – | – |
| Net Income | -$12 | -$10 | -$13 | -$11 |
| % Margin | – | – | – | – |
| EPS Diluted | -10.25 | -5.89 | -6.84 | -5.47 |
| % Growth | -74% | 13.9% | -25% | – |
| Operating Cash Flow | -$7 | -$10 | -$13 | -$11 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$7 | -$10 | -$13 | -$11 |